Combining antidepressants to hasten remission from depression
Phase of Trial: Phase IV
Latest Information Update: 07 Oct 2017
At a glance
- Drugs Bupropion (Primary) ; Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 26 Jun 2012 Additional lead trial centre(National Institute of Mental Health (NIMH)) identified as reported by ClinicalTrials.gov.
- 26 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2012 Actual patient number is 245 according to ClinicalTrials.gov.